KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Revenue (2016 - 2025)

Historic Revenue for Incyte (INCY) over the last 16 years, with Q3 2025 value amounting to $1.4 billion.

  • Incyte's Revenue rose 2004.7% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 billion, marking a year-over-year increase of 1808.81%. This contributed to the annual value of $4.2 billion for FY2024, which is 1476.24% up from last year.
  • Per Incyte's latest filing, its Revenue stood at $1.4 billion for Q3 2025, which was up 2004.7% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Incyte's Revenue ranged from a high of $1.4 billion in Q3 2025 and a low of $604.7 million during Q1 2021
  • In the last 5 years, Incyte's Revenue had a median value of $919.0 million in 2023 and averaged $944.9 million.
  • In the last 5 years, Incyte's Revenue surged by 3099.11% in 2021 and then surged by 126.89% in 2022.
  • Over the past 5 years, Incyte's Revenue (Quarter) stood at $862.9 million in 2021, then increased by 7.4% to $926.7 million in 2022, then grew by 9.35% to $1.0 billion in 2023, then rose by 16.32% to $1.2 billion in 2024, then rose by 15.89% to $1.4 billion in 2025.
  • Its Revenue stands at $1.4 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.1 billion for Q1 2025.